(PharmaNewsWire.Com, January 15, 2018 ) GBI Research's latest report, "Life Cycle Management Strategies - Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.
Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.
- Introduction of LCM and product life cycle - Objectives of LCM and factors impacting the choice of strategies - LCM strategies depending on the way of approach - Impact of LCM strategies on sales and growth trend of selected products - Patent term extension and market exclusivity in the US and Europe - LCM strategies of pipeline drugs of key players - Keys to successful implementation of LCM strategies
- Identify the key LCM strategies used by most of the pharmaceutical companies - Analyze the strategies to increase lifecycle and revenues of a drug - Gain an understanding on the implementation of multiple strategies for a single product by including case studies - Understand the operational pipeline strategies of key players
Executive Summary Introduction Overview of Product Life Cycle Product Life Cycle Curve Objectives of Life Cycle Management (LCM) Classification and Benefits of LCM Strategies Strategic Planning for LCM Factors Impacting Choice of LCM Strategies Developmental Strategies Indication Expansion/Sequencing and Repositioning Patient Subpopulations and Personalized Medicine Reformulation New Dosage Forms New Route of Administration Special Cases New Dosage Strengths and Regimen Fixed-Dose Combination and Co-packaging Next Generation Products and Modified Chemistry Metabolites Chiral Switching Polymorphs Multiple Developmental Strategy Approach Commercial Strategies Rx-to-OTC/BTC Switch Geographical Expansion Pricing Strategy and Tactics Pricing Strategy for Targeting Multiple Indications Coupons Co-pay Cards Awareness, Brand Loyalty and Service Programs Regulatory and Legal Strategies Authorized Generics Legal Defense and Pay for Delay Citizen's Petition Patent Term Extension and Market Exclusivity The Pharmaceutical Pipeline and LCM Successful Implementation of LCM Strategies Appendix Market Outlook Key Market Players Biosimilars Pipeline Analysis Overview By Stage of Development By Molecule By Therapy Area By Indication By MoA/RoA Late-Stage Pipeline Biosimilars Phase II Pipeline Biosimilars Phase I Pipeline Biosimilars
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: